Back to Results
First PageMeta Content
Medicine / Medical equipment / Medical technology / Propel mometasone furoate implant / Intersect ENT / RTT / Sinus implant / Sinusitis / Sinus / Otorhinolaryngology / Frontal sinus / Paranasal sinuses


Intersect ENT Announces FDA Submission to Seek Expanded Indication of PROPEL Mini Steroid Releasing Implant to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—September 29, 2015—Intersect ENT, Inc. (Nasd
Add to Reading List

Document Date: 2015-09-29 20:19:21


Open Document

File Size: 119,75 KB

Share Result on Facebook